Company Overview of Medarex, Inc.
Medarex, Inc. discovers, develops, and commercializes human antibody-based therapeutic products for the treatment of oncology, inflammation, autoimmune disorders, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. It has research facilities in Milpitas and Sunnyvale, California; a research and development facility in Greenwich Township, New Jersey; and a manufacturing facility in Annandale, New Jersey. As of August 31, 2009, Medarex, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
707 State Road
Princeton, NJ 08540-1437
Founded in 1987
Key Executives for Medarex, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Medarex, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.